TY - JOUR AU - Koizumi, W. AU - Narahara, H. AU - Hara, T. AU - Takagane, A. AU - Akiya, T. AU - Takagi, M. PY - 2008 DA - 2008// TI - S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial JO - Lancet Oncol. VL - 9 UR - https://doi.org/10.1016/S1470-2045(08)70035-4 DO - 10.1016/S1470-2045(08)70035-4 ID - Koizumi2008 ER - TY - JOUR AU - Yamada, Y. AU - Takahari, D. AU - Matsumoto, H. AU - Baba, H. AU - Nakamura, M. AU - Yoshida, K. PY - 2013 DA - 2013// TI - Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70490-X DO - 10.1016/S1470-2045(13)70490-X ID - Yamada2013 ER - TY - JOUR AU - Okamoto, I. AU - Yoshioka, H. AU - Morita, S. AU - Ando, M. AU - Takeda, K. AU - Seto, T. PY - 2010 DA - 2010// TI - Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naive patients with advanced non-small-cell lung cancer: results of a West Japan oncology group study JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2010.31.0326 DO - 10.1200/JCO.2010.31.0326 ID - Okamoto2010 ER - TY - JOUR AU - Shirasaka, T. AU - Nakano, K. AU - Takechi, T. AU - Satake, H. AU - Uchida, J. AU - Fujioka, A. PY - 1996 DA - 1996// TI - Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats JO - Cancer Res VL - 56 ID - Shirasaka1996 ER - TY - JOUR AU - Shirasaka, T. AU - Shimamato, Y. AU - Ohshimo, H. AU - Yamaguchi, M. AU - Kato, T. AU - Yonekura, K. PY - 1996 DA - 1996// TI - Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators JO - Anti-Cancer Drugs VL - 7 UR - https://doi.org/10.1097/00001813-199607000-00010 DO - 10.1097/00001813-199607000-00010 ID - Shirasaka1996 ER - TY - JOUR AU - Shirasaka, T. AU - Shimamoto, Y. AU - Fukushima, M. PY - 1993 DA - 1993// TI - Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats JO - Cancer Res VL - 53 ID - Shirasaka1993 ER - TY - JOUR AU - Fujita, K. AU - Yamamoto, W. AU - Endo, S. AU - Endo, H. AU - Nagashima, F. AU - Ichikawa, W. PY - 2008 DA - 2008// TI - CYP2A6 and the plasma level of 5-chloro-2, 4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1 JO - Cancer Sci VL - 99 UR - https://doi.org/10.1111/j.1349-7006.2008.00773.x DO - 10.1111/j.1349-7006.2008.00773.x ID - Fujita2008 ER - TY - JOUR AU - Ikeda, M. AU - Furukawa, H. AU - Imamura, H. AU - Shimizu, J. AU - Ishida, H. AU - Masutani, S. PY - 2002 DA - 2002// TI - Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor agent in animal model and in patients with impaired renal function JO - Cancer Chemother Pharmacol VL - 50 UR - https://doi.org/10.1007/s00280-002-0457-z DO - 10.1007/s00280-002-0457-z ID - Ikeda2002 ER - TY - JOUR AU - Bender, B. C. AU - Schindler, E. AU - Friberg, L. E. PY - 2015 DA - 2015// TI - Population pharmacokinetic–pharmacodynamic modelling in oncology: a tool for predicting clinical response JO - Br J Clin Pharmacol VL - 79 UR - https://doi.org/10.1111/bcp.12258 DO - 10.1111/bcp.12258 ID - Bender2015 ER - TY - JOUR AU - Yabusaki, N. AU - Fujii, T. AU - Yamada, S. AU - Murotani, K. AU - Sugimoto, H. AU - Kanda, M. PY - 2016 DA - 2016// TI - The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma-including the analysis of clinicopathological factors influencing relative dose intensity JO - Medicine (Baltimore) VL - 95 UR - https://doi.org/10.1097/MD.0000000000004282 DO - 10.1097/MD.0000000000004282 ID - Yabusaki2016 ER - TY - JOUR AU - Kitagawa, M. AU - Shimura, T. AU - Yamada, T. AU - Ebi, M. AU - Hirata, Y. AU - Mizoshita, T. PY - 2012 DA - 2012// TI - The relationship between antitumor effects and relative dose intensity of S-1 plus cisplatin treatment for metastatic gastric cancer JO - Anticancer Res VL - 32 ID - Kitagawa2012 ER - TY - JOUR AU - Matsuo, S. AU - Imai, E. AU - Horio, M. AU - Yasuda, Y. AU - Tomita, K. AU - Nitta, K. PY - 2009 DA - 2009// TI - Revised equations for estimated GFR from serum creatinine in Japan JO - Am J Kidney Dis VL - 53 UR - https://doi.org/10.1053/j.ajkd.2008.12.034 DO - 10.1053/j.ajkd.2008.12.034 ID - Matsuo2009 ER - TY - STD TI - Common Terminology Criteria for Adverse Events (CTCAE) v4.0. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_40. Accessed 31 July 2018. UR - https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_40 ID - ref13 ER - TY - JOUR AU - Lyman, G. H. AU - Kuderer, N. M. AU - Crawford, J. AU - Wolff, D. A. AU - Culakova, E. AU - Poniewierski, M. S. PY - 2011 DA - 2011// TI - Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy JO - Cancer VL - 117 UR - https://doi.org/10.1002/cncr.25691 DO - 10.1002/cncr.25691 ID - Lyman2011 ER - TY - JOUR AU - Ray-Coquard, I. AU - Borg, C. AU - Bachelot, T. AU - Sebban, C. AU - Philip, I. AU - Clapisson, G. PY - 2003 DA - 2003// TI - Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy JO - Br J Cancer VL - 88 UR - https://doi.org/10.1038/sj.bjc.6600724 DO - 10.1038/sj.bjc.6600724 ID - Ray-Coquard2003 ER - TY - JOUR AU - Ray-Coquard, I. AU - Le Cesne, A. AU - Rubio, M. T. AU - Mermet, J. AU - Maugard, C. AU - Ravaud, A. PY - 1999 DA - 1999// TI - Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 study group JO - J Clin Oncol VL - 17 UR - https://doi.org/10.1200/JCO.1999.17.9.2840 DO - 10.1200/JCO.1999.17.9.2840 ID - Ray-Coquard1999 ER - TY - JOUR AU - Zahorec, R. PY - 2001 DA - 2001// TI - Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill JO - Bratisl Lek Listy VL - 102 ID - Zahorec2001 ER - TY - JOUR AU - Pallis, A. G. AU - Agelaki, S. AU - Kakolyris, S. AU - Kotsakis, A. AU - Kalykaki, A. AU - Vardakis, N. PY - 2008 DA - 2008// TI - Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel-gemcitabine chemotherapy JO - Lung Cancer VL - 62 UR - https://doi.org/10.1016/j.lungcan.2008.03.030 DO - 10.1016/j.lungcan.2008.03.030 ID - Pallis2008 ER - TY - JOUR AU - Yamanaka, T. AU - Matsumoto, S. AU - Teramukai, S. AU - Ishiwata, R. AU - Nagai, Y. AU - Fukushima, M. PY - 2007 DA - 2007// TI - Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma JO - Br J Cancer VL - 97 UR - https://doi.org/10.1038/sj.bjc.6603831 DO - 10.1038/sj.bjc.6603831 ID - Yamanaka2007 ER - TY - JOUR AU - Lissoni, P. AU - Brivio, F. AU - Fumagalli, L. AU - Messina, G. AU - Ghezzi, V. AU - Frontini, L. PY - 2004 DA - 2004// TI - Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors JO - Int J Biol Markers VL - 19 UR - https://doi.org/10.1177/172460080401900208 DO - 10.1177/172460080401900208 ID - Lissoni2004 ER - TY - JOUR AU - Aspinall, S. L. AU - Good, C. B. AU - Zhao, X. AU - Cunningham, F. E. AU - Heron, B. B. AU - Geraci, M. PY - 2015 DA - 2015// TI - Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1038-y DO - 10.1186/s12885-015-1038-y ID - Aspinall2015 ER - TY - JOUR AU - Kim, S. J. AU - Kim, Y. J. AU - Kim, J. H. AU - Park, D. J. AU - Kim, H. H. AU - Lee, J. S. PY - 2013 DA - 2013// TI - Safety, compliance, and predictive parameters for dosage modification in adjuvant S-1 chemotherapy for gastric cancer JO - Cancer Sci VL - 104 UR - https://doi.org/10.1111/cas.12044 DO - 10.1111/cas.12044 ID - Kim2013 ER - TY - JOUR AU - Kawazoe, H. AU - Shimasaki, M. AU - Ueno, M. AU - Sumikawa, S. AU - Takatori, S. AU - Namba, H. PY - 2015 DA - 2015// TI - Risk factors for discontinuation of s-1 adjuvant chemotherapy for gastric cancer JO - J Cancer VL - 6 UR - https://doi.org/10.7150/jca.11189 DO - 10.7150/jca.11189 ID - Kawazoe2015 ER - TY - JOUR AU - Borg, C. AU - Ray-Coquard, I. AU - Philip, I. AU - Clapisson, G. AU - Bendriss-Vermare, N. AU - Menetrier-Caux, C. PY - 2004 DA - 2004// TI - CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer JO - Cancer VL - 101 UR - https://doi.org/10.1002/cncr.20688 DO - 10.1002/cncr.20688 ID - Borg2004 ER - TY - JOUR AU - Yokoyama, M. AU - Kusano, Y. AU - Takahashi, A. AU - Inoue, N. AU - Ueda, K. AU - Nishimura, N. PY - 2017 DA - 2017// TI - Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan JO - Support Care Cancer VL - 25 UR - https://doi.org/10.1007/s00520-017-3747-z DO - 10.1007/s00520-017-3747-z ID - Yokoyama2017 ER - TY - JOUR AU - Zhang, L. AU - Yu, Q. AU - Wu, X. C. AU - Hsieh, M. C. AU - Loch, M. AU - Chen, V. W. PY - 2018 DA - 2018// TI - Impact of chemotherapy relative dose intensity on cause-specific and overall survival for stage I-III breast cancer: ER+/PR+, HER2- vs. triple-negative JO - Breast Cancer Res Treat VL - 169 UR - https://doi.org/10.1007/s10549-017-4646-1 DO - 10.1007/s10549-017-4646-1 ID - Zhang2018 ER -